Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood

Blood

Volumn 89, Issue 11, 1997, Pages 3967-3973

  Urbano Ispizua, Alvaro ^a   Rozman, Ciril ^a,b   Martínez, Carmen ^a   Marín, Pedro ^a   Briones, Javier ^a   Rovira, Montserrat ^a   Féliz, Pedro ^a   Viguria, Maria Cruz ^a   Merino, Ana ^a   Sierra, Jorge ^a   Mazzara, Roberto ^a   Carreras, Enric ^a   Montserrat, Emilio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CELL MOTILITY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HISTIOCYTOSIS X; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOADSORPTION; LUNG ASPERGILLOSIS; MALE; PRIORITY JOURNAL; PROPHYLAXIS; REFRACTORY ANEMIA; REMISSION; STATISTICAL ANALYSIS; WHOLE BODY RADIATION;

EID: 0030964190     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.11.3967     Document Type: Article

References (43)

1. Goldman J: Peripheral blood stem cells for allografting. Blood 85:1413, 1995
2. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
3. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Löffler H, Hunter AE, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995
4. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host-disease. Blood 86:2842, 1995
5. Russell JA, Luider J, Weaver M, Brown C, Selinger S, Railton C, Karlsson L, Klessen J: Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 15:111, 1995
6. Russell NH, Hunter AE: Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 13:353, 1994
7. Appelbaum FR: Allogeneic bone marrow transplantation for malignancy-current problems and prospects for improvement, in Magrath I (ed): New Directions in Cancer Treatment. New York, NY, Springer-Verlag, 1989, p 143
8. van Bekkum D: Graft-versus-host disease, in van Bekkum DW, Lowenberg B (eds): Bone Marrow Transplantation: Biological Mechanisms and Clinical Practice. New York, NY, Dekker, 1985, p 147
9. + marrow cells for autologous marrow transplantation, in Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ (eds): Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium. Houston, TX, M.D. Anderson, 1989, p 55
10. + hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation. Exp Hematol 23:320, 1995
11. Poynton CH: T cell depletion in bone marrow transplantation. Bone Marrow Transplant 3:265, 1988
12. Marmont A, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA, Herzig RH, Hong R, Masaoka T, Rimm AA, Speck B, Weiner RS, Bortin MM: T-cell depletion of HLA-identical transplants in leukemia. Blood 78:2120, 1991
13. Yeisner Y, Martelli MF: Succesful engraftment of T-cell depleted incompatible bone marrow supplemented with peripheral blood stem cells: From animal models to clinical application in leukemia patients. Bone Marrow Transplant 15:S112, 1995 (suppl 1)
14. + cell dose predicts survival, postransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 88:3223, 1996
15. Thomas ED, Storb R, Clift RA, Fefer M, Johnson FL, Neiman PF, Lerner KG, Glucksberg H, Buckner CD: Bone marrow transplantation. N Engl J Med 292:832, 1975
16. Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA, Thomas ED: Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6:1562, 1988
17. Schattenberg A, De Whitte T, Preijers F, Raemaekers J, Muus P, Van Der Lely N, Boezeman J, Wessels J, Van Dijk B, Hoogenhout J, Haanen C: Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation. Blood 75:1356, 1990
18. Martin P, Hansen JA, Buckner CD, Sanders JE, Deeg J, Stewart P, Appelbaum FR, Clift R, Fefer A, Witherspoon RP, Kennedy MS, Sullivan KM, Flournoy N, Storb R, Thomas ED: Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66:664, 1984
19. Patterson J, Prentice HG, Brenner MK, Gilmore M, Janossy G, Ivory K, Skeggs D, Morgan H, Lord J, Blacklock HA, Hoffbrand AV, Apperley JF, Goldman JM, Burnett A, Gribben J, Alcorn M, Pearson C, McVickers I, Hann IM, Reid C, Wardle D, Gravett J, Bacigalupo A, Robertson AG: Graft failure following HLA matched T-lymphocyte depleted bone marrow transplantation. Br J Haematol 221:63, 1986
20. Verdonck LF, de Gast GC, van Heugten HG, Deckker A: A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation. Blood 75:776, 1990
21. Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C, Iacucci R, Zei T, Martelli MP, Gambelunghe C, Rosetti M, Caputo P, Latini P, Aristei C, Raymondi C, Reisner Y, Martelli M: Succesful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84:3948, 1994
22. Bachar-Lusting E, Rachamin N, Li HW, Lan F, Reisner Y: Megadose of T-cell depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nature Med 1:1268, 1995
23. Verdonck LF, Dekker AW, de Gast GC, van Kempen ML, Lokhorst HM, Nieuwenhuis HK: Allogeneic bone marrow transplantation with fixed low number of T cells in the marrow graft. Blood 83:3090, 1994
24. Champling R, Ho W, Gajewski J, Feig S, Burnison M, Holley G, Greenberg P, Lee K, Schmid I, Giorgi J, Yam P, Petz L, Winston D, Warner N, Reichter T: Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood 76:418, 1990
25. Young JW, Papadopoulos EB, Cunningham I, Castro-Malaspina H, Flomenberg N, Carabasi MH, Gulati SC, Brochstein JA, Heller G, Black P, Collins NH, Shank B, Kernan NA, O'Reilly RJ: T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission. Blood 79:3380, 1992
26. Soiffier RJ, Murray C, Mauch P, Anderson KC, Freedman AS, Rabinowe SN, Takvorian T, Robertson MJ, Spector N, Gonin R, Miller KB, Rudders RA, Freeman A, Blake K, Coral F, Nadler LM, Ritz J: Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. J Clin Oncol 10:1191, 1992
27. Lowenberg B, Wagemaker G, van Bekkum DW, Sizoo W, Sintnicolaas K, Hendriks WDH, Hagenbeek A: Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors. Bone Marrow Transplant 1:133, 1986
28. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Loffler H, Muller-Ruchholtz W, Schmitz N: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol 87:609, 1994
29. Bensinger W, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, Williams B, Storb R, Thomas ED, Buckner CD: The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 81:1883, 1993
30. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 84:1421, 1994
31. +-selected peripheral blood progenitor cells mobilized by recombinant granulocyte- and granulocyte-macrophage colony-stimulating factors. Blood 86:2052, 1994 (letter)
32. + blood cells. Blood 87:4903, 1996
33. + peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 88:4132, 1996
34. + progenitor cells from matched related donors. Bone Marrow Transplant 18:1081, 1996
35. Urbano-Ispizua A, Solano C, Brunet S, Hernández F, Sanz G, Alegre A, Petit J, Besalduch J, Vivancos P, Díaz MA, Moraleda JM, Carreras E, Ojeda E, Rubia de la J, Benet I, Domingo-Albós A, García-Conde J, Rozman C: Allogeneic peripheral blood progenitor cells transplantation: Analysis of short-term engraftment and acute GVHD incidence in 33 cases. Bone Marrow Transplant 18:35, 1996
36. Majolino I, Saglio G, Scime R, Serra A, Cavallero AM, Fiandaca T, Vasta S, Pampinella M, Catania P, Indovina A, Marceno R, Santoro A: High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 17:555, 1996
37. Anderlini P, Przepiorka D, Khouri I, van Beslen K, Mehra R, Giralt S, Gajewski J, Cleary K, Champlin RE, Andersson B, Korbling M: Chronic graft-vs-host disease (GVHD) after allogeneic marrow or blood stem cell transplantation. Blood 86:108a, 1995 (suppl 1)
38. Urbano-Ispizua A, García-Conde J, Brunet S, Hernández F, Sanz G, Alegre A, Petit J, Bargay J, Vivancos P, Solano C, Ojeda E, Domingo A, Rozman C: High incidence of chronic GVHD after allogeneic peripheral blood progenitor cell transplantation from matched related donors. Blood 88:617a, 1996 (suppl 1)
39. Herenstein B, Hampl W, Bunjes D: In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. Bone Marrow Transplant 15:387, 1995
40. Bacigalupo A, Tedone E, Isaza A, Soracco M, Van Lint MT, Sanna A, Frassoni F, Occhini D, Gualandi F, Lamparelli T, Figari O, Benvenuto F, Raffo MR, Marmont AM: CMV-antigenemia after allogeneic bone marrow transplantation: Correlation of CMV-antigen positive cell numbers with transplant-related mortality. Bone Marrow Transplant 16:155, 1995
41. Couriel D, Canosa J, Engler H, Collins A, Dunbar C, Barret AJ: Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow Transplant 18:347, 1996
42. + cells. Blood 88:599a, 1996 (suppl 1)
43. + selected cells PBPCT. Blood 88:261a, 1996 (suppl 1)